InvestorsHub Logo
Followers 240
Posts 12425
Boards Moderated 0
Alias Born 08/14/2003

Re: None

Sunday, 02/13/2022 12:37:58 AM

Sunday, February 13, 2022 12:37:58 AM

Post# of 1106
IMGN gets an outperform rating, and $18 target.

https://thefly.com/landingPageNews.php?id=3457364&headline=IMGN-ImmunoGen-initiated-with-an-Outperform-at-BMO-Capital

In the Annual Report later this month I'd not be surprised to have them announce the filing of the BLA. A partnership before the end of the year might very well bring well above the $18 target.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMGN News